Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase

Journal of Lipid Research

Volumn 47, Issue 12, 2006, Pages 2754-2761

  Matsukuma, Karen E ^a   Bennett, Mary K ^a   Huang, Jiansheng ^b   Wang, Li ^b   Gil, Gregorio ^c   Osborne, Timothy F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Farnesoid X receptor; Nuclear receptors; Small heterodimer partner

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DIET SUPPLEMENTATION; ENZYME REGULATION; IMMUNOPRECIPITATION; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; BILE ACIDS AND SALTS; BINDING SITES; CELL LINE; DNA; DNA-BINDING PROTEINS; FATTY ACID SYNTHETASE COMPLEX; HUMANS; LIPOGENESIS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 33845573067     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600342-JLR200     Document Type: Article

References (45)

1. Schmucker, D. L., M. Ohta, S. Kanai, Y. Sato, and K. Kitani. 1990. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology. 12: 1216-1221.
2. Spivey, J. R., S. F. Bronk, and G. J. Gores. 1993. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J. Clin. Invest. 92: 17-24.
3. Forman, B. M., E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, et al. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81: 687-693.
4. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science. 284: 1362-1365.
5. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284: 1365-1368.
6. Wang, H., J. Chen, K. Hollister, L. C. Sowers, and B. M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3: 543-553.
7. Grober, J., I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono, and P. Besnard. 1999. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274: 29749-29754.
8. Ananthanarayanan, M., N. Balasubramanian, M. Makishima, D. J. Mangelsdorf, and F. J. Suchy. 2001. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276: 28857-28865.
9. Jung, D., M. Podvinec, U. A. Meyer, D. J. Mangelsdorf, M. Fried, P. J. Meier, and G. A. Kullak-Ublick. 2002. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology. 122: 1954-1966.
10. Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell. 6: 507-515.
11. Goodwin, B., S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, et al. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 6: 517-526.
12. del Castillo-Olivares, A., and G. Gil. 2001. Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. Nucleic Acids Res. 29: 4035-4042.
13. Inagaki, T., M. Choi, A. Moschetta, L. Peng, C. L. Cummins, J. G. McDonald, G. Luo, S. A. Jones, B. Goodwin, J. A. Richardson, et al. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2: 217-225.
14. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140.
15. Peet, D. J., S. D. Turley, W. Ma, B. A. Janowski, J-M. A. Lobaccard, R. E. Hammer, and D. J. Mangelsdorf. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell. 93: 693-704.
16. Repa, J. J., S. D. Turley, J. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 289: 1524-1529.
17. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA. 98: 507-512.
18. Luo, Y., and A. R. Tall. 2000. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. 105: 513-520.
19. Angelin, B., K. Einarsson, K. Hellstrom, and B. Leijd. 1978. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J. Lipid Res. 19: 1017-1024.
20. Bateson, M. C., M. D. Evans, Jr., and I. A. Bouchier. 1978. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Br. J. Clin. Pharmacol. 5: 249-254.
21. Bell, G., B. Lewis, A. Petrie, and R. Dowling. 1973. Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. BMJ. 3: 520-523.
22. Watanabe, M., S. M. Houten, L. Wang, A. Moschetta, D. J. Mangelsdorf, R. A. Heyman, D. D. Moore, and J. Auwerx. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113: 1408-1418.
23. Moustaid, N., K. Sakamoto, S. Clarke, R. S. Beyer, and H. S. Sul. 1993. Regulation of fatty acid synthase gene transcription. Biochem. J. 292: 767-772.
24. Moustaid, N., R. S. Beyer, and H. S. Sul. 1994. Identification of an insulin response element in the fatty acid synthase promoter. J. Biol. Chem. 269: 5629-5634.
25. Wolf, S. S., G. Hofer, K. F. Beck, K. Roder, and M. Schweizer. 1994. Insulin-responsive regions of the rat fatty acid synthase gene promoter. Biochem. Biophys. Res. Commun. 203: 943-950.
26. Ishii, S., K. Iizuka, B. C. Miller, and K. Uyeda. 2004. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. USA. 101: 15597-15602.
27. Xiong, S., S. S. Chirala, M. H. Hsu, and S. J. Wakil. 1998. Identification of thyroid hormone response elements in the human fatty acid synthase promoter. Proc. Natl. Acad. Sci. USA. 95: 12260-12265.
28. Clarke, S. D., M. K. Armstrong, and D. B. Jump. 1990. Dietary polyunsaturated fats uniquely suppress rat liver fatty acid synthase and S14 mRNA content. J. Nutr. 120: 225-231.
29. Bennett, M. K., J. M. Lopez, H. B. Sanchez, and T. F. Osborne. 1995. Sterol regulation of fatty acid synthase promoter. J. Biol. Chem. 270: 25578-25583.
30. Joseph, S. B., B. A. Laffitte, P. H. Patel, M. A. Watson, K. E. Matsukuma, R. Walczak, J. L. Collins, T. F. Osborne, and P. Tontonoz. 2002. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277: 11019-11025.
31. Yieh, L., H. B. Sanchez, and T. F. Osborne. 1995. Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter. Proc. Natl. Acad. Sci. USA. 92: 6102-6106.
32. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by SREBP and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270: 1161-1169.
33. Zhang, C., D. J. Shin, and T. F. Osborne. 2005. A simple promoter containing two Sp1 sites controls the expression of sterol-regulatory-element- binding protein 1a (SREBP-1a). Biochem. J. 386: 161-168.
34. del Castillo-Olivares, A., and G. Gil. 2000. Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J. Biol. Chem. 275: 17793-17799.
35. Lopez, J. M., M. K. Bennett, H. B. Sanchez, J. M. Rosenfeld, and T. F. Osborne. 1996. Sterol regulation of acetyl CoA carboxylase: a mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. USA. 93: 1049-1053.
36. Bennett, M., J. I. Toth, and T. F. Osborne. 2004. Selective association of sterol regulatory element binding protein isoforms with target promoters in vivo. J. Biol. Chem. 279: 37360-37367.
37. Laffitte, B. A., H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, and P. A. Edwards. 2000. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275: 10638-10647.
38. Sinal, C. J., M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, and F. J. Gonzalez. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 102: 731-744.
39. Pircher, P. C., J. L. Kitto, M. L. Petrowski, R. K. Tangirala, E. D. Bischoff, I. G. Schulman, and S. K. Westin. 2003. Farnesoid X receptor regulates bile acid-amino acid conjugation. J. Biol. Chem. 278: 27703-27711.
40. Downes, M., M. A. Verdecia, A. J. Roecker, R. Hughes, J. B. Hogenesch, H. R. Kast-Woelbern, M. E. Bowman, J. L. Ferrer, A. M. Anisfeld, P. A. Edwards, et al. 2003. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell. 11: 1079-1092.
41. Dussault, I., R. Beard, M. Lin, K. Hollister, J. Chen, J. H. Xiao, R. Chandraratna, and B. M. Forman. 2003. Identification of gene-selective modulators of the bile acid receptor FXR. J. Biol. Chem. 278: 7027-7033.
42. Lew, J. L., A. Zhao, J. Yu, L. Huang, N. De Pedro, F. Pelaez, S. D. Wright, and J. Cui. 2004. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J. Biol. Chem. 279: 8856-8861.
43. Warner, G. J., G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat. 1995. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270: 5772-5778.
44. Stroup, D., and J. Y. L. Chiang. 2000. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7{alpha}-hydroxylase gene (CYP7A1). J. Lipid Res. 41: 1-11.
45. Claudel, T., Y. Inoue, O. Barbier, D. Duran-Sandoval, V. Kosykh, J. Fruchart, J. C. Fruchart, F. J. Gonzalez, and B. Staels. 2003. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 125: 544-555.